Active Share (vs S&P 500): 96.9%
· vs QQQ: 97.8%
— share of the book that differs from index weights (higher = more active)
· ranking
Est. Qtr Return (Q2 2026 → Q3 2026):
+0.3%
· vs SPY
-1.8%
· Prev Value $746.95M
— last quarter positions weighted by this quarter price moves
· ranking
Est. QTD Return (Q3 2026 → newest close):
+0.1%
· vs SPY
-2.1%
· Latest Value $598.80M
— latest reported positions valued at quarter-to-date price moves (still in progress)
· ranking
In its Q3 2026 13F filing, Defilade Capital Management, L.P. disclosed 30 equity positions with a combined reported value of $598.80M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were PFE ($43.49M), LLY ($40.24M), BMRN ($36.12M). By sector, the heaviest allocations are Health Care 93.7%, Technology 3.3%. Versus the prior quarter, allocation shifted toward Health Care (+4.0pp) and away from Industrials (-0.5pp), Other (-1.2pp).
Versus the prior quarter, Defilade Capital Management, L.P. opened 8 new positions, trimmed 11 and fully exited 17, a turnover rate of 76.6% of positions. The portfolio's overlap with the prior quarter was 47% of names.
The largest new positions opened in Q3 2026 were GILD ($33.77M), AXSM ($32.34M), AMGN ($31.23M).
Of the 17 positions fully exited versus the prior quarter, the largest were PTCT ($35.38M), BAX ($31.11M), INSM ($30.05M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Latest Defilade Capital Management, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Defilade Capital Management, L.P. is an SEC-registered 13F filer based in Emeryville, CA, United States. As of Q2 2026 it reported 39 US equity positions with a combined value of $746.95M. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).
Regulatory AUM (Form ADV): $1.55B as of 2026-06-26
Client mix (by RAUM): pension and profit-sharing plans 100%
Manages 1 private funds, of which 1 hedge funds
Website: defcap.com
Portfolio Structure
39 positions · $746.95M reported value (Q2 2026)
Top 10 holdings = 46.5% of reported value
Largest position: LLY (ELI LILLY & CO) at 6.3%
Average position size: $19.15M
Sector Tilt
Health Care 89.7%
Information Technology 5.6%
Industrials 3.5%
(classified holdings cover 99% of value)
Quarterly Activity
Q2 2026: 19 new, 8 added, 10 reduced, 11 exited
2 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-16.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.
Portfolio return+9.06%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+26.08%vs benchmark
Barra annualised vol20.2%Model estimate
Realised vol25.7%Annualised in window
Weighted beta0.49Raw exposure
Factor / specific risk62% / 38%Share of variance
Top-10 concentration100.0%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
+9.06%
Disclosed long book
QQQ synthetic benchmark
-17.01%
Liquidity-weighted constituents
Model universe, equal weight
-1.70%
Opportunity-cost reference
Excess return
+26.08%
Portfolio − benchmark
Arithmetic return sum
+9.11%
Difference vs compounded is the cross term
Weighted raw beta
0.49
Weighted holding betas
Realised volatility (annualised)
25.70%
Daily returns in window
Barra model volatility (annualised)
20.25%
Factor + specific
Factor share of variance
62.4%
Barra factors
Specific share of variance
37.6%
Stock residuals
Reported value
$182.2M
13F long US equity
2. Return attribution
The +9.11% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
+0.57%
6.3%
Momentum & Growth
3
-1.91%
-21.0%
Volatility & Tail Risk
7
+5.57%
61.1%
Industry
12
+6.32%
69.4%
Specific
1
-1.45%
-15.9%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Health Care
Industry
+0.90
+6.98%
+6.30%
69.2%
Historical Volatility
Style
-0.31
-14.00%
+4.27%
46.9%
Skewness
Style
-0.40
-4.39%
+1.76%
19.4%
Turnover
Style
-0.35
-4.80%
+1.67%
18.3%
Residual Volatility
Style
+0.37
+3.29%
+1.22%
13.3%
Kurtosis
Style
+0.08
+7.51%
+0.59%
6.5%
Amihud Illiquidity
Style
-0.54
-0.45%
+0.24%
2.6%
Liquidity
Style
+0.52
+0.36%
+0.19%
2.0%
Growth
Style
+0.04
+1.75%
+0.06%
0.7%
Mid Cap
Style
+0.06
-1.94%
-0.11%
-1.2%
Short-term Reversal
Style
-0.23
+0.87%
-0.20%
-2.2%
Leverage (Downside Vol)
Style
+0.36
-1.71%
-0.62%
-6.8%
Non-linear Size
Style
-0.64
+1.01%
-0.65%
-7.1%
Size
Style
+0.39
-1.95%
-0.77%
-8.4%
Specific
Specific
—
—
-1.45%
-15.9%
Beta
Style
-0.38
+4.44%
-1.70%
-18.7%
Momentum
Style
+0.44
-4.00%
-1.77%
-19.5%
3. Risk attribution
Annualised volatility is 20.25%; factor risk explains 62.4% of variance and specific risk 37.6%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Health Care
Industry
+0.90
49.7%
+10.07%
10.1%
Specific
Specific
—
37.6%
+7.62%
7.6%
Momentum
Style
+0.44
3.7%
+0.76%
0.8%
Liquidity
Style
+0.52
3.6%
+0.74%
0.7%
Historical Volatility
Style
-0.31
2.9%
+0.58%
0.6%
Amihud Illiquidity
Style
-0.54
2.1%
+0.43%
0.4%
Industrials
Industry
+0.10
2.1%
+0.42%
0.4%
Non-linear Size
Style
-0.64
1.9%
+0.39%
0.4%
Kurtosis
Style
+0.08
0.3%
+0.05%
0.1%
Turnover
Style
-0.35
0.2%
+0.05%
0.1%
Size
Style
+0.39
-0.4%
-0.07%
-0.1%
Short-term Reversal
Style
-0.23
-0.7%
-0.13%
-0.1%
Leverage (Downside Vol)
Style
+0.36
-0.7%
-0.14%
-0.1%
Beta
Style
-0.38
-2.7%
-0.54%
-0.5%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
+0.39
+2.10
-1.71
Non-linear Size
-0.64
+1.68
-2.32
Mid Cap
+0.06
+0.13
-0.07
Beta
-0.38
+1.29
-1.68
Momentum
+0.44
+0.72
-0.27
Short-term Reversal
-0.23
-0.64
+0.41
Residual Volatility
+0.37
-0.40
+0.77
Historical Volatility
-0.30
+0.86
-1.17
Liquidity
+0.53
+0.11
+0.41
Amihud Illiquidity
-0.54
+1.16
-1.69
Turnover
-0.35
+0.21
-0.55
Growth
+0.04
+0.58
-0.55
Leverage (Downside Vol)
+0.36
+0.14
+0.22
Skewness
-0.40
+0.24
-0.64
Kurtosis
+0.08
+0.21
-0.14
Max Drawdown
-0.03
-0.08
+0.06
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
0.0%
73.6%
+0.00%
-22.33%
+3.83%
+16.44%
-16.44%
+16.44%
Health Care
90.2%
1.7%
+9.91%
+8.29%
+22.49%
+0.03%
+1.44%
+8.79%
Communication Services
0.0%
2.6%
+0.00%
-17.64%
+0.01%
+0.46%
-0.46%
+0.46%
Utilities
0.0%
0.8%
+0.00%
+11.13%
-0.22%
-0.09%
+0.09%
-0.09%
Consumer Staples
0.0%
0.8%
+0.00%
+15.26%
-0.27%
-0.13%
+0.13%
-0.13%
Industrials
9.8%
11.1%
+2.41%
+4.36%
-0.28%
-0.22%
+0.03%
-0.25%
Consumer Discretionary
0.0%
8.8%
+0.00%
+3.76%
-1.84%
-0.33%
+0.33%
-0.33%
Total
+23.60%
+16.14%
-14.86%
+24.87%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
LLY
ELI LILLY & CO
Health Care
22.08%
+23.73%
+5.24%
Reduce
GILD
GILEAD SCIENCES INC
Health Care
18.53%
+12.43%
+2.30%
New
AMGN
AMGEN INC
Health Care
17.13%
+9.68%
+1.66%
New
ISRG
INTUITIVE SURGICAL INC
Health Care
16.03%
+7.65%
+1.23%
New
TMO
THERMO FISHER SCIENTIFIC INC
Industrials
9.80%
+2.41%
+0.24%
Reduce
BSX
BOSTON SCIENTIFIC CORP
Health Care
8.40%
+0.09%
+0.01%
New
RVMD
REVOLUTION MEDICINES INC
Health Care
8.02%
-18.70%
-1.50%
Reduce
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
LLY
Health Care
22.08%
+23.73%
+5.24%
2
GILD
Health Care
18.53%
+12.43%
+2.30%
3
AMGN
Health Care
17.13%
+9.68%
+1.66%
4
ISRG
Health Care
16.03%
+7.65%
+1.23%
5
TMO
Industrials
9.80%
+2.41%
+0.24%
6
BSX
Health Care
8.40%
+0.09%
+0.01%
7
RVMD
Health Care
8.02%
-18.70%
-1.50%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +9.06%, versus -17.01% for the QQQ synthetic benchmark — an excess of +26.08%.
Return attribution: the largest positive style/industry contributions came from Health Care +6.30%, Historical Volatility +4.27%, Skewness +1.76%; the largest drags came from Momentum -1.77%, Beta -1.70%, Size -0.77%. Specific (stock-level) return contributed -1.45%.
Risk attribution: Barra model volatility is 20.25% annualised; factor risk explains 62% of variance and specific risk 38%. The largest factor risk sources are Health Care 49.7%, Momentum 3.7%, Liquidity 3.6%.
Style tilt: size +0.39, momentum +0.44, volatility -0.30, liquidity +0.53; the weighted raw beta is 0.49. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Health Care (+88.5 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.60%, selection +16.14% and interaction -14.86%.
Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did Defilade Capital Management, L.P. buy in 2026-Q3?
In its 2026-Q3 13F filing, Defilade Capital Management, L.P. reported 30 equity positions worth $598.80M in aggregate; its largest disclosed positions were PFE ($43.49M), LLY ($40.24M), BMRN ($36.12M).
How large is Defilade Capital Management, L.P.'s portfolio?
Defilade Capital Management, L.P. reported $598.80M of long equity holdings across 30 positions as of 2026-Q3. Top-10 holdings account for 54.9% of reported value.
What is Defilade Capital Management, L.P.'s investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/defilade-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>